Communiqués QHSLab, Inc.

Actions

USAQ

US90350R1077

Temps Différé OTC Markets Autres places de cotation 15:30:00 07/06/2024			Varia. 5j.	Varia. 1 janv.
0,25 ^USD	+55,18%		+38,89%	+177,78%

13/05	QHSLab, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
27/03	QHSLab, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

QHSLab, Inc. Announces Strong First Quarter 2024 Results with Significant Reduction in Operating Expenses and Positive Net Operating Income	13/05	AQ
QHSLab, Inc. Enhances Leadership Team with Dr. Marcos Sanchez-Gonzalez as New VP of Medical and Scientific Affairs	02/05	AQ
QHSLab, Inc. Announces Preliminary Unaudited First Quarter Revenue Results	26/04	AQ
QHSLab Announces Impressive 2023 Fiscal Year Results with Growing Revenues, Improved Gross Margins, and Substantial Reduction in Net Loss	28/03	AQ
QHSLab Integrates Digital Medicine Assessments into Prominent Electronic Health Record (EHR) Company	30/01	AQ
QHSLab, Inc. (USAQ) Reports Third Quarter Financial Results	14/11	AQ
QHSLab Welcomes Six New Integrated Service Program (ISP) Customer Accounts and Launches Enhanced Website for Improved Customer Engagement	25/10/23	AQ
QHSLab Continues to Lead the Way in Digital Healthcare with Impressive Year-to-Date Achievements in Patient-Centric Innovations and Advancements in Behavioral Healthcare	18/10/23	AQ
QHSLab, Inc. Reports First Quarter Financial Results	15/05/23	AQ
QHSLAB, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS AND OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	29/03/23	AQ
QHSLAB, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	16/02/23	AQ
QHSLab, Inc. Announces Representation Agreement with Healthcare Information Technology Specialists of Florida	16/02/23	AQ
QHSLAB, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	30/01/23	AQ
QHSLab, Inc. Reiterates its 2022 Projection of a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care	30/01/23	AQ
QHSLAB, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	14/11/22	AQ
QHSLab, Inc. Projects a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care	14/11/22	GL
QHSLab, Inc. Projects a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care	14/11/22	AQ
QHSLAB, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	14/11/22	AQ
QHSLAB, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	01/11/22	AQ
QHSLab, Inc. Meets the Demand for Updated Mental Health Screening Recommendations from the U.S. Preventive Services Task Force	01/11/22	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués QHSLab, Inc.

Actions

USAQ

US90350R1077

Communiqués

Filtres